Psoriasis Study Shows a Path for Considering US Drug Costs Psoriasis Study Shows a Path for Considering US Drug Costs

Only three of 13 psoriasis biologics appeared to be cost-effective based on US prices in a new analysis. The finding may aid policymakers struggling with drug price negotiations.Medscape Medical News

Source: Medscape Dermatology Headlines - March 8, 2024 Category: Dermatology Tags: Dermatology Source Type: news